Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.
Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...
HealthDay News — A once-promising investigational vaccine against herpes viruses showed only 20% efficacy against herpes genital disease in a large clinical trial designed to mimic the general ...
Infection with the herpes simplex virus (HSV) is for life. Although HSV-2 is the main cause of genital herpes, HSV-1 – the virus responsible for cold sores – can be transmitted by oral sex, so it, too ...
The rise of sexually transmitted infections (STIs) continues to pose threats. The prevalence of one uncurable STI in particular – genital herpes simplex virus (HSV) type 1 and 2 – is at a global high, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results